## Abstract Tyrosine kinase inhibitors (TKIs) as sorafenib are known to reduce the number of immunosuppressive regulatory T cells (Tregs) in the peripheral blood and thereby shifting the immune balance to a more stimulating setting. The effect of sorafenib on intratumoural Tregs is unclear but impo
The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function
✍ Scribed by Jessica Herrath; Malin Müller; Petra Amoudruz; Peter Janson; Jakob Michaëlsson; Per T. Larsson; Christina Trollmo; Sukanya Raghavan; Vivianne Malmström
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 381 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Unwanted tissue reactions are often observed resulting in events such as early resorption of the biomaterial, loosening of the implant, or a chronic (immunologic) response. From immunologic studies it is known that inflammatory reactions can be modulated by use of (anti)-growth factors or anti-infla
IL-12 promotes Th1 cell differentiation and cell-mediated immunity. In the present study, the potential role of IL-12 was analyzed in an experimental colitis model in scid mice reconstituted with syngeneic CD45RB high CD4 + T cells. Real-time reverse transcription-PCR studies demonstrated that IL-12